Literature DB >> 17392853

From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma.

Robert W Nickells1.   

Abstract

Even with exhaustive investigation, however, there is still little understanding of the pathologic events that translate increased IOP into the process of retinal ganglion cell death. New studies, particularly in rat and mouse models of glaucoma, have helped elucidate some of the important events associated with the initiation of glaucoma. This review summarizes a 5-stage series hypothesizing that elevated IOP causes deleterious changes to glia in the optic nerve head (stage 1), which activate the autonomous self-destruction of ganglion cell axons (stage 2), leading to the loss of neurotrophic support and apoptotic death of ganglion cell somas in the retina (stage 3). In the initial wave of ganglion cell death, dying cells may adversely affect their neighbouring cells in a wave of secondary degeneration involving glutamate exposure (stage 4). As ganglion cell structures disappear through the processes of cell death, glia are again involved, but this time to replace the lost neural tissue with a glial scar (stage 5).

Entities:  

Mesh:

Year:  2007        PMID: 17392853     DOI: 10.3129/can j ophthalmol.i07-036

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  70 in total

1.  Progressive degeneration of retinal and superior collicular functions in mice with sustained ocular hypertension.

Authors:  Hui Chen; Yan Zhao; Mingna Liu; Liang Feng; Zhen Puyang; Ji Yi; Peiji Liang; Hao F Zhang; Jianhua Cang; John B Troy; Xiaorong Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-26       Impact factor: 4.799

2.  Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes.

Authors:  Matthew M Harper; Sinisa D Grozdanic; Bas Blits; Markus H Kuehn; Daniel Zamzow; Janice E Buss; Randy H Kardon; Donald S Sakaguchi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-23       Impact factor: 4.799

3.  The morphology and spatial arrangement of astrocytes in the optic nerve head of the mouse.

Authors:  Daniel Sun; Ming Lye-Barthel; Richard H Masland; Tatjana C Jakobs
Journal:  J Comp Neurol       Date:  2009-09-01       Impact factor: 3.215

4.  Intraocular pressure fluctuations in professional brass and woodwind musicians during common playing conditions.

Authors:  Gunnar Schmidtmann; Susanne Jahnke; Egbert J Seidel; Wolfgang Sickenberger; Hans-Jürgen Grein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-14       Impact factor: 3.117

5.  TRPC6: an underlying target for human glaucoma.

Authors:  Qian Fan; Wen-Bin Huang; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

Review 6.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

7.  Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location.

Authors:  Liang Feng; Yan Zhao; Miho Yoshida; Hui Chen; Jessica F Yang; Ted S Kim; Jianhua Cang; John B Troy; Xiaorong Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-07       Impact factor: 4.799

8.  Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.

Authors:  Katherine T Janssen; Caitlin E Mac Nair; Joel A Dietz; Cassandra L Schlamp; Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

Review 9.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

10.  A single nucleotide polymorphism in the Bax gene promoter affects transcription and influences retinal ganglion cell death.

Authors:  Sheila J Semaan; Yan Li; Robert W Nickells
Journal:  ASN Neuro       Date:  2010-03-31       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.